Abstract:Boron neutron capture therapy (BNCT) is a treatment modality that combines different radiation qualities. Since the severity of biological damage following irradiation depends on the radiation type, a quantity different from absorbed dose is required to explain the effects observed in the clinical BNCT in terms of outcome compared with conventional photon radiation therapy. A new approach for calculating photon iso-effective doses in BNCT was introduced previously. The present work extends this model to include information from dose-response assessments in animal models and humans. Parameters of the model were determined for tumour and precancerous tissue using dose-response curves obtained from BNCT and photon studies performed in the hamster cheek pouch in vivo models of oral cancer and/or pre-cancer, and from head and neck cancer radiotherapy data with photons. To this end, suitable expressions of the dose-limiting Normal Tissue Complication and Tumour Control Probabilities for the reference radiation and for the mixed field BNCT radiation were developed. Pearson's correlation coefficients and p-values showed that TCP and NTCP models agreed with experimental data (with r > 0.87 and p-values >0.57). The photon iso-effective dose model was applied retrospectively to evaluate the dosimetry in tumours and mucosa for head and neck cancer patients treated with BNCT in Finland. Photon iso-effective doses in tumour were lower than those obtained with the standard RBE-weighted model (between 10% to 45%). The results also suggested that the probabilities of tumour control derived from photon iso-effective doses are more adequate to explain the clinical responses than those obtained with the RBE-weighted values. The dosimetry in the mucosa revealed that the photon iso-effective doses were about 30% to 50% higher than the corresponding RBE-weighted values. While the RBE-weighted doses are unable to predict mucosa toxicity, predictions based on the proposed model are compatible with the observed clinical outcome. The extension of the photon iso-effective dose model has allowed, for the first time, the determination of the photon iso-effective dose for unacceptable complications in the dose-limiting normal tissue. Finally, the formalism developed in this work to compute photon-equivalent doses can be applied to other therapies that combine mixed radiation fields, such as hadron therapy.

Study of photon interaction parameters in malignant and healthy breast tissues using experimentally determined trace elements

Non-invasive in vivo characterization of breast tumors using photon migration spectroscopy

Relative electron density determination using a physics based parameterization of photon interactions in medical DECT

TH-E-M100J-04: Quantitative Assessment of Tissue Toxicity in Breast Cancer Radiation Therapy Using Spectrophotometry and Ultrasonic Tissue Characterization Imaging

Analysis of Trace Elements in Breast Tumor Tissues

Characterization of breast tissues in density and effective atomic number basis via spectral x-ray computed tomography

Complementary techniques for the reliable characterisation of tissue samples: A case study on pancreatic tumours analysed by means of X-ray fluorescence analysis and IR spectroscopy

Spectrophotometer and Ultrasound Evaluation of Late Toxicity Following Breast-Cancer Radiotherapy.

Study of gamma, neutron, and proton interaction parameters of some immunotherapy drugs using EpiXs, NGCal, and PSTAR software

Optical parameters of healthy and tumor breast tissues in mice

Radiation attenuation characterization of some biological samples by using the Klein–Nishina formula

Comparison between concentrations of trace elements in normal and neoplastic human breast tissue

Electromagnetic Characterization of Breast Tissue Phantoms in D-Band Regime

Three-dimensional x-ray fluorescence mapping of a gold nanoparticle-loaded phantom

Photon iso-effective dose for cancer treatment with mixed field radiation based on dose-response assessment from human and an animal model: clinical application to boron neutron capture therapy for head and neck cancer

Time-domain scanning optical mammography: II. Optical properties and tissue parameters of 87 carcinomas

Trace Metal Distribution and Correlation to Breast Cancer Progression and Metastasis Based on Synchrotron Radiation X-ray Fluorescence Imaging

Toolkit for Determination of Dose-response Relations, Validation of Radiobiological Parameters and Treatment Plan Optimization Based on Radiobiological Measures

Investigation of Exposure Factors for Various Breast Composition and Thicknesses in Digital Screening Mammography Related to Breast Dose

Quantitative Ultrasonic Evaluation of Radiation-Induced Late Tissue Toxicity: Pilot Study of Breast Cancer Radiotherapy

Monte Carlo calculated photon interaction coefficients for several body tissues